MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-06-0022696
Endocard India Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.21 Cr
▲ 8% YoY
Net profit · FY 2025
₹9.77 Lakh
Net margin 1.4%
EBITDA · FY 2025
₹33.08 Lakh
EBITDA margin 4.6%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹20.02 Lakh
Issued & subscribed
Open charges
₹4.31 Cr
Satisfied ₹1.11 Cr
Company age
27 yrs
Est. 1999
Employees · EPFO
12
Provident fund records
About Endocard India Private Limited
Data last updated:
Endocard India Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 February 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL1999PTC098174. Its GSTIN is 07AAACE8644H1ZK (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹20.02 Lakh. It is led by directors Rajiv Khurana and Shakuntla Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 205 Blue Star Plaza Opp. M2K 2nd Floor Sarja Market Sector – 7 Rohini, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.21 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹9.77 Lakh (net margin 1.4%) and EBITDA of ₹33.08 Lakh (EBITDA margin 4.6%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 5% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.31 Cr and satisfied charges of ₹1.11 Cr on record. Court records list 6 cases involving the company, including 3 filed by the company and 3 filed against it; 2 cases are pending.
Endocard India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0022696). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website endocardindia.com.
Company details
CIN U24239DL1999PTC098174
Registration Number 098174
Incorporation Date 01 February 1999
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-06-0022696
Key People
Rajiv Khurana Director Shakuntla Devi Director Recognitions & Rankings of Endocard India
Contact details
Endocard India Private Limited's registered office is in New Delhi, Delhi. Its website is endocardindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address205 Blue Star Plaza Opp. M2K 2nd Floor Sarja Market Sector – 7 Rohini, New Delhi, Delhi, India – 110085
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Endocard India Private Limited, buy the company report.
Comprehensive company report
Endocard India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Endocard India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Endocard India Private Limited, buy the company report.
Financials of Endocard India Private Limited
FY 2025 filings availableEndocard India Private Limited reported revenue of ₹7.21 Cr (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹7.21 Cr ▲ 8%
Net profit · FY 2025
₹9.77 Lakh margin 1.4%
EBITDA · FY 2025
₹33.08 Lakh margin 4.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 12%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 3%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 8% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.77 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.6% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Endocard India Private Limited, buy the company report.
Board of directors of Endocard India Private Limited
Endocard India has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajiv Khurana Also directs: C and C Organics Private Limited, C&C Healthcares Private Limited | Director | 01 Feb 1999 | 27 Years 8 Months | Current |
| Shakuntla Devi | Director | 01 Feb 1999 | 27 Years 8 Months | Current |
Peer comparison
Endocard India Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Speciality Meditech Private Limited | ₹7.27 Cr (FY 2024) | 9.0% | Jaipur, Rajasthan, India | |||
| Rejli Healthcare Private Limited | ₹7.24 Cr (FY 2025) | 304.0% | Jhnasi, Uttar Pradesh, India | |||
| Minova Life Sciences Private Limited | ₹7.22 Cr (FY 2024) | 2.0% | Bengaluru, Karnataka, India | |||
| Endocard India Private Limitedthis company | ₹7.21 Cr (FY 2025) | ₹9.77 Lakh | 1.4% | 8.0% | 12 | New Delhi, Delhi, India |
| Avs Med Laboratories Private Limited | ₹7.18 Cr (FY 2024) | 59.0% | Chandauli, Uttar Pradesh, India | |||
| Vatave Pharmacls India Private Limited | ₹7.17 Cr (FY 2025) | 13.0% | Chandigarh, India |
To see the full peer comparison of Endocard India Private Limited, buy the company report.
Auditor
Endocard India Private Limited is audited by M K NAGPAL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M K NAGPAL & ASSOCIATES | FY 2021 | 013031N |
Shareholding
The shareholding of Endocard India Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Endocard India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.31 Cr
Satisfied charges
₹1.11 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jan 2012 | 10334791 | Others | ₹3.8 Cr | Open | |
| 31 Mar 2011 | 10298527 | Citi Bank Na | ₹51 Lakh | Open | |
| 22 Mar 2016 | 100017078 | Others | ₹75 Lakh | Satisfied | |
| 16 Jul 2009 | 10170080 | Icici Home Finance Company Limited | ₹36 Lakh | Satisfied |
To see the full charge records of Endocard India Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Endocard India Private Limited has 6 court cases on record: 3 filed by Endocard India, 3 filed against it. 2 cases are pending and 4 are disposed.
Total cases
6
Filed by the company
3
Filed against the company
3
Pending
2
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 2 | 2 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Criminal case | Filed by the company against Dynamic Medi Waves Pvt. Ltd. | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against Nishant Enterprises Through Its Proprietor Mr Pawan KR Hetmapuria | Pending |
| District court, North West, Delhi | Civil suit | Filed by the company against an individual | Disposed |
| District court, Ahmedabad, Gujarat | Court case (SPCS EL) | Filed against the company by Cadiala Healthcare Ltd. | Disposed |
| High Court, GUJARAT | Special civil application | Filed against the company by Cadila Healthcare Ltd | Disposed |
To see the full case history of Endocard India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Endocard India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Endocard India Private Limited has a workforce of 12 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
12
Active EPFO establishments
1
Employee growth
-14.29%
GST
Endocard India has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACE8644H1ZK | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Endocard India Private Limited, buy the company report.
Recent activity
Endocard India Private Limited has 2 board changes on record since 1999: 2 appointments. The latest: Rajiv Khurana was appointed as Director on 01 Feb 1999.
AGM
Endocard India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Endocard India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others of Rs. 380.00 Lakh registered on 30 Jan 2012 with Charge ID 10334791 was modified on 16 Dec 2024.
Charges
A charge registered on 22 Mar 2016 via Charge ID 100017078 with Others was fully satisfied on 12 Dec 2024.
Charges
A charge with Others of Rs. 75.00 Lakh registered on 22 Mar 2016 with Charge ID 100017078 was modified on 28 Jan 2021.
Charges
A charge with Others amounted to Rs. 75.00 Lakh with Charge ID 100017078 was registered on 22 Mar 2016.
Charges
A charge with Others amounted to Rs. 380.00 Lakh with Charge ID 10334791 was registered on 30 Jan 2012.
Charges
A charge registered on 16 Jul 2009 via Charge ID 10170080 with Icici Home Finance Company Limited was fully satisfied on 30 Apr 2011.
Charges
A charge with Citi Bank Na amounted to Rs. 51.00 Lakh with Charge ID 10298527 was registered on 31 Mar 2011.
Charges
A charge with Icici Home Finance Company Limited amounted to Rs. 36.00 Lakh with Charge ID 10170080 was registered on 16 Jul 2009.
Appointed
Rajiv Khurana was appointed as Director.
Appointed
Shakuntla Devi was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Endocard India is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 February 1999 (27+ years old) and is registered under CIN U24239DL1999PTC098174.
Endocard India has 2 current directors:
- Rajiv Khurana - Director
- Shakuntla Devi - Director
The latest financial statements of Endocard India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Endocard India is 07AAACE8644H1ZK, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Endocard India is U24239DL1999PTC098174. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Endocard India has 6 court cases on record: 3 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.
Endocard India was incorporated on 01 February 1999, making it 27+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Endocard India by revenue are Speciality Meditech Private Limited, Rejli Healthcare Private Limited, Minova Life Sciences Private Limited, Avs Med Laboratories Private Limited, Vatave Pharmacls India Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Rajiv Khurana was appointed as Director on 01 Feb 1999. Shakuntla Devi was appointed as Director on 01 Feb 1999.
Yes, Endocard India is registered as a small enterprise under Udyam registration (number: UDYAM-DL-06-0022696).
Endocard India can be reached through the website endocardindia.com. Its registered office is in New Delhi, Delhi, India.